“We have already demonstrated scientifically that our process and product is exceptional.”Jason Matuszewski, Chief Executive OfficerSeptember 26, 2023BioStem Technologies (OTC: BSEM) has received Investigational Review Board (IRB) approval for a clinical study that will investigate the utilization and effects of its Vendaje Ⓡ wound care product in diabetic foot ulcers.“We have already demonstrated scientifically that our process and product is exceptional. This study will enhance...
![](https://prismmediawire.com/wp-content/uploads/2023/09/Biostem-main-logo--1080x412.png)